| Age (years) Mean (median, range) |
49.7 years (55, 10–84 years) |
| Gender |
Male |
66 (39.5%) |
| Female |
101 (60.5%) |
| Spherical Equivalent (diopters) Mean (median, range) |
-0.48 (0.0, -5.63 to 4.3) |
| BCVA |
20/15 |
5 (7.5%) |
| 20/20 |
126 (71.6%) |
| 20/25 |
23 (13.0%) |
| 20/30 |
11 (6.3%) |
| 20/40 |
2 (1.2%) |
| Lens Status |
Phakic |
146 (87.4%) |
| Pseudophakic |
21 (12.6%) |
| Laterality |
Right |
87 (52.1%) |
| Left |
80 (47.9%) |
| Reason for OCT |
Hydroxychloroquine use |
39 (23.4%) |
| Uveitis/endophthalmitis, contralateral eye |
24 (12.2%) |
| Baseline (initial visit) |
19 (11.3%) |
| Retinal vein occlusion, contralateral eye |
17 (10.2%) |
| CSR, contralateral eye |
14 (8.4%) |
| Macular hole, contralateral eye |
14 (8.4%) |
| Retinal detachment or retinal tear, contralateral eye |
12 (7.2%) |
| Cataract evaluation, contralateral eye |
11 (8.4%) |
| Macular edema, contralateral eye |
9 (5.4%) |
| ERM, contralateral eye |
8 (4.8%) |
| History of diabetes |
4 (2.4%) |
| AMD, contralateral eye |
2 (1.2%) |
| Coats disease, contralateral eye |
1 (0.6%) |
